OPTIMUS HEALTHCARE SERVICES, INC.

EDGAR

Market value is not computed: no listed ticker is recorded for this company.

15 filing records in this dataset, filed from 2021-12-22 to 2024-11-21. Reported financial figures are available; chart coverage varies by period.

Watchlist

Holdings and insider activity

Transactions reported by directors, officers and 10% owners on SEC Forms 3, 4 and 5, over the last 12 months.

No Form 3, 4 or 5 for this issuer is in the store. The store has read filings dated 2004-06-14 to 2026-11-18; this is not a statement that none were filed.

See all insider transactions

Latest quarter

Revenue

385 thousand USD

2024 Q3 · USD

Exact inputs and evidence

Operating margin

-416.21%

2024 Q3 · %

Exact inputs and evidence
  • Operating Income: -1601430 USD Source
  • Revenue: 384763 USD Source

Operating cash flow

83.9 thousand USD

2024 Q3 · USD

Exact inputs and evidence
  • Operating Cash Flow: -281772 USD Source
  • Operating Cash Flow: -365650 USD Source
Cash and cash equivalents
152 thousand USD Source
Exact value

152357 USD

Long-term debt including current maturities
Not available
Shares outstanding
47.9 million shares Source
Exact value

47906664 shares

Reported share-count change

19.86% · 7.94 million shares

Year-over-year change in reported shares. Splits, issuance and buybacks can affect this figure; it does not isolate employee compensation or economic dilution.

Exact inputs and evidence
  • 39967598 shares · 2023-09-30· Source
  • 47906664 shares · 2024-09-30· Source

Trailing twelve months

The four most recent complete quarters added together. This gives a full-year view that includes the latest quarterly results.

Revenue

1.82 million USD

2023-10-01 – 2024-09-30

Exact inputs and evidence
  • Revenue: 1497779 USD · 2023-01-01 – 2023-12-31 Source
  • Revenue: 1047773 USD · 2023-01-01 – 2023-09-30 Source
  • Revenue: 344465 USD · 2024-01-01 – 2024-03-31 Source
  • Revenue: 639303 USD · 2024-04-01 – 2024-06-30 Source
  • Revenue: 384763 USD · 2024-07-01 – 2024-09-30 Source

Net income

-7.19 million USD

2023-10-01 – 2024-09-30

Exact inputs and evidence
  • Net income: -11103503 USD · 2023-01-01 – 2023-12-31 Source
  • Net income: -7592961 USD · 2023-01-01 – 2023-09-30 Source
  • Net income: -423487 USD · 2024-01-01 – 2024-03-31 Source
  • Net income: -1451067 USD · 2024-04-01 – 2024-06-30 Source
  • Net income: -1806532 USD · 2024-07-01 – 2024-09-30 Source

Operating cash flow

-800 thousand USD

2023-10-01 – 2024-09-30

Exact inputs and evidence
  • Operating cash flow: -3686663 USD · 2023-01-01 – 2023-12-31 Source
  • Operating cash flow: -3168858 USD · 2023-01-01 – 2023-09-30 Source
  • Operating cash flow: -126954 USD · 2024-01-01 – 2024-03-31 Source
  • Operating cash flow: -365650 USD · 2024-01-01 – 2024-06-30 Source
  • Operating cash flow: -126954 USD · 2024-01-01 – 2024-03-31 Source
  • Operating cash flow: -281772 USD · 2024-01-01 – 2024-09-30 Source
  • Operating cash flow: -365650 USD · 2024-01-01 – 2024-06-30 Source

Company performance

Up to ten complete financial years · consolidated figures

Includes later revisions to earlier periods. Annual charts exclude incomplete years.

Latest filing recorded: 2024-11-21.

Financial data available through: 2023-12-31.

Coverage by financial measure
  • Revenue: 3 of 11 periods available· newest 2023-12-31
  • Operating income: 3 of 11 periods available· newest 2023-12-31
  • Net income: 3 of 11 periods available· newest 2023-12-31
  • Operating cash flow: 3 of 11 periods available· newest 2023-12-31
  • capital expenditure: No compatible figures in this window
  • Total assets: 3 of 11 periods available· newest 2023-12-31
  • Total liabilities: 3 of 11 periods available· newest 2023-12-31
  • Current assets: 3 of 11 periods available· newest 2023-12-31
  • Current liabilities: 3 of 11 periods available· newest 2023-12-31
  • Cash and cash equivalents: 3 of 11 periods available· newest 2023-12-31
  • long term debt: No compatible figures in this window
  • Shares outstanding: 3 of 11 periods available· newest 2023-12-31

Coverage describes values retained in this snapshot. Missing values are not zero; loading limits are reported separately.

What changed year over year

Latest complete year compared with the corresponding period one year earlier. These are measured changes; they do not establish their business causes.

  • Revenue

    +22.9%

    Prior period

    USD 1.22 million

    –

    Current period

    USD 1.5 million

    –

    Exact inputs and evidence

    1497779 − 1218882 = 278897 USD

    1218882 USD · 2022-01-01 – 2022-12-31

    Inspect prior input Prior source

    1497779 USD · 2023-01-01 – 2023-12-31

    Inspect current input Current source
    Share or cite

    The citation records this snapshot. The page link may show a newer release later.

  • Net income

    −USD 378,320

    Prior period

    −USD 10.73 million

    –

    Current period

    −USD 11.1 million

    –

    Exact inputs and evidence

    -11103503 − -10725183 = -378320 USD

    -10725183 USD · 2022-01-01 – 2022-12-31

    Inspect prior input Prior source

    -11103503 USD · 2023-01-01 – 2023-12-31

    Inspect current input Current source
    Share or cite

    The citation records this snapshot. The page link may show a newer release later.

  • Operating cash flow

    +USD 350,679

    Prior period

    −USD 4.04 million

    –

    Current period

    −USD 3.69 million

    –

    Exact inputs and evidence

    -3686663 − -4037342 = 350679 USD

    -4037342 USD · 2022-01-01 – 2022-12-31

    Inspect prior input Prior source

    -3686663 USD · 2023-01-01 – 2023-12-31

    Inspect current input Current source
    Share or cite

    The citation records this snapshot. The page link may show a newer release later.

Comparable inputs unavailable for: Capital expenditure.

Where revenue goes

How a period’s revenue divides into costs and what remains as profit. Items marked Derived are calculated by subtraction from reported figures.

2023 2023-01-01 – 2023-12-31

  • Revenue USD 1.5 million 100% of revenue
  • Cost of revenue USD 284,420 19% of revenue
  • Operating expenses USD 9.79 million 653% of revenue
  • Operating income −USD 8.57 million −572% of revenue
  • Tax, interest and other Derived USD 2.53 million 169% of revenue
  • Net income −USD 11.1 million −741% of revenue

Cash

  • Operating cash flow −USD 3.69 million −246% of revenue
  • Capital expenditure Unavailable An input is unavailable.
  • Free cash flow Derived Unavailable An input is unavailable.

Share of revenue by period

  • Net income
  • Tax, interest and other
  • Operating costs
  • 2021 Operating loss: operating costs were 1,036% of revenue.
  • 2022 Operating loss: operating costs were 762% of revenue.
  • 2023 Operating loss: operating costs were 672% of revenue.
Values and sources
Revenue breakdown by annual reporting period
PeriodRevenueOperating costsOperating incomeTax, interest and otherNet incomeFree cash flowSource
2021 2021-01-01 – 2021-12-31827266 8567044 Derived -7739778 12313 Derived -7752091 Unavailable
Source
2022 2022-01-01 – 2022-12-311218882 9285053 Derived -8066171 2659012 Derived -10725183 Unavailable
Source
2023 2023-01-01 – 2023-12-311497779 10070684 Derived -8572905 2530598 Derived -11103503 Unavailable
Source

Amounts are exact, in USD.

Growth

Sales over time and how quickly they are changing.

Revenue

Revenue reported for each complete financial period.

USD 1.5M 2023
Revenue historyRevenue reported for each complete financial period. Values are shown by financial reporting period. Open Values and sources below for the exact observations and evidence.1.6M1.2M808.8K404.4K0.0202120222023
Values and sources
Revenue values and source evidence
PeriodSeriesValue(USD)Source evidence
2021Revenue827266
2022Revenue1218882
2023Revenue1497779

Revenue growth

Change in revenue from the same financial period one year earlier.

22.9% 2023
Revenue growth historyChange in revenue from the same financial period one year earlier. Values are shown by financial reporting period. Open Values and sources below for the exact observations and evidence.51%38%26%13%0%202120222023
Values and sources
Revenue growth values and source evidence
PeriodSeriesValueSource evidence
2021Year over yearNo prior comparable period
2022Year over year47.3%
2023Year over year22.9%

Profit and cash

How much revenue becomes profit, and how much cash operations generate.

Profit margins

Operating income, net income and free cash flow as a share of revenue.

Operating margin -572.4% 2023
Net margin -741.3% 2023
Profit margins historyOperating income, net income and free cash flow as a share of revenue. Values are shown by financial reporting period. Open Values and sources below for the exact observations and evidence.75%-197%-469%-740%-1,012%202120222023
  • Operating margin
  • Net margin
  • Free cash flow margin
Values and sources
Profit margins values and source evidence
PeriodSeriesValueSource evidence
2021Operating margin-935.6%
2022Operating margin-661.8%
2023Operating margin-572.4%
2021Net margin-937.1%
2022Net margin-879.9%
2023Net margin-741.3%
2021Free cash flow marginNot reported
2022Free cash flow marginNot reported
2023Free cash flow marginNot reported

Operating cash flow

Cash generated by the company’s normal business operations.

USD -3.7M 2023
Operating cash flow historyCash generated by the company’s normal business operations. Values are shown by financial reporting period. Open Values and sources below for the exact observations and evidence.323.0K-847.8K-2.0M-3.2M-4.4M202120222023
Values and sources
Operating cash flow values and source evidence
PeriodSeriesValue(USD)Source evidence
2021Operating cash flow-2754054
2022Operating cash flow-4037342
2023Operating cash flow-3686663

Free cash flow

Operating cash flow minus capital expenditure for the same period and unit.

Not enough comparable data to show this history.
Values and sources
Free cash flow values and source evidence
PeriodSeriesValue(USD)Source evidence
2021Free cash flowUnavailable
2022Free cash flowUnavailable
2023Free cash flowUnavailable

Balance sheet

Liabilities and short-term ability to meet obligations at each period end.

Liabilities to assets

Total liabilities as a share of total assets.

767.3% 2023
Liabilities to assets historyTotal liabilities as a share of total assets. Values are shown by financial reporting period. Open Values and sources below for the exact observations and evidence.829%622%414%207%0%202120222023
Values and sources
Liabilities to assets values and source evidence
PeriodSeriesValueSource evidence
2021Liabilities / assets31%
2022Liabilities / assets155.9%
2023Liabilities / assets767.3%

Current assets to current liabilities

Current assets divided by current liabilities.

0.1× 2023
Current assets to current liabilities historyCurrent assets divided by current liabilities. Values are shown by financial reporting period. Open Values and sources below for the exact observations and evidence.1.56×1.17×0.78×0.39×0.00×202120222023
Values and sources
Current assets to current liabilities values and source evidence
PeriodSeriesValueSource evidence
2021Current assets / current liabilities1.44×
2022Current assets / current liabilities1.13×
2023Current assets / current liabilities0.1×

Cash generation

Compare reported profit with operating cash and capital spending. Free cash flow is calculated as operating cash flow minus capital expenditure when both exact, consolidated amounts match the same period and unit.

Cash generation by annual reporting period
PeriodNet incomeOperating cash flowCapital expenditureFree cash flow
2021 2021-01-01 – 2021-12-31
−USD 7.75 million
Exact value

Exact value: -7752091 USD

2021-01-01 – 2021-12-31: -7752091 USD Inspect Net Income Open source
Share or cite

The citation records this snapshot. The page link may show a newer release later.

−USD 2.75 million
Exact value

Exact value: -2754054 USD

2021-01-01 – 2021-12-31: -2754054 USD Inspect Operating Cash Flow Open source
Share or cite

The citation records this snapshot. The page link may show a newer release later.

Unavailable Not reported for this period.
Unavailable

Free cash flow cannot be calculated because Capital expenditure is unavailable for this period.

2022 2022-01-01 – 2022-12-31
−USD 10.73 million
Exact value

Exact value: -10725183 USD

2022-01-01 – 2022-12-31: -10725183 USD Inspect Net Income Open source
Share or cite

The citation records this snapshot. The page link may show a newer release later.

−USD 4.04 million
Exact value

Exact value: -4037342 USD

2022-01-01 – 2022-12-31: -4037342 USD Inspect Operating Cash Flow Open source
Share or cite

The citation records this snapshot. The page link may show a newer release later.

Unavailable Not reported for this period.
Unavailable

Free cash flow cannot be calculated because Capital expenditure is unavailable for this period.

2023 2023-01-01 – 2023-12-31
−USD 11.1 million
Exact value

Exact value: -11103503 USD

2023-01-01 – 2023-12-31: -11103503 USD Inspect Net Income Open source
Share or cite

The citation records this snapshot. The page link may show a newer release later.

−USD 3.69 million
Exact value

Exact value: -3686663 USD

2023-01-01 – 2023-12-31: -3686663 USD Inspect Operating Cash Flow Open source
Share or cite

The citation records this snapshot. The page link may show a newer release later.

Unavailable Not reported for this period.
Unavailable

Free cash flow cannot be calculated because Capital expenditure is unavailable for this period.

Capital expenditure uses the canonical mapped positive-spending convention. A missing, ambiguous, incompatible, or negative-sign input is left blank. Values use the latest reported version.

Dataset coverage and company identifiers

Coverage reflects filings processed into this Fundies dataset; it does not imply every source filing is loaded.

15 filings · 954 latest values · 954 originally reported values

Dataset published . Source filing dates and reporting periods are shown separately.

Identifiers: 0001892025, 1892025, edgar:1892025

Also known as OPTIMUS HEALTHCARE SERVICES, INC., Optimus Healthcare Services, Inc.